nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.102	0.188	CbGbCtD
Thioridazine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0887	0.163	CbGbCtD
Thioridazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0738	0.136	CbGbCtD
Thioridazine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0619	0.114	CbGbCtD
Thioridazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.059	0.108	CbGbCtD
Thioridazine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0499	0.0918	CbGbCtD
Thioridazine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0373	0.0686	CbGbCtD
Thioridazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0289	0.0531	CbGbCtD
Thioridazine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0265	0.0487	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0162	0.0298	CbGbCtD
Thioridazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0139	0.131	CbGeAlD
Thioridazine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00765	0.0717	CbGeAlD
Thioridazine—HTR6—ganglion—peripheral nervous system neoplasm	0.00634	0.0595	CbGeAlD
Thioridazine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00582	0.0547	CbGeAlD
Thioridazine—HTR7—pons—peripheral nervous system neoplasm	0.00576	0.054	CbGeAlD
Thioridazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0051	0.0478	CbGeAlD
Thioridazine—DRD1—nerve—peripheral nervous system neoplasm	0.00478	0.0448	CbGeAlD
Thioridazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00477	0.0447	CbGeAlD
Thioridazine—DRD1—ganglion—peripheral nervous system neoplasm	0.00472	0.0443	CbGeAlD
Thioridazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00366	0.0344	CbGeAlD
Thioridazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00363	0.0341	CbGeAlD
Thioridazine—HTR2A—pons—peripheral nervous system neoplasm	0.00359	0.0337	CbGeAlD
Thioridazine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00308	0.0289	CbGeAlD
Thioridazine—HTR7—nerve—peripheral nervous system neoplasm	0.00299	0.028	CbGeAlD
Thioridazine—HTR7—ganglion—peripheral nervous system neoplasm	0.00295	0.0277	CbGeAlD
Thioridazine—DRD2—nerve—peripheral nervous system neoplasm	0.00282	0.0265	CbGeAlD
Thioridazine—DRD2—ganglion—peripheral nervous system neoplasm	0.00279	0.0262	CbGeAlD
Thioridazine—DRD1—brainstem—peripheral nervous system neoplasm	0.00205	0.0192	CbGeAlD
Thioridazine—HTR2A—nerve—peripheral nervous system neoplasm	0.00186	0.0175	CbGeAlD
Thioridazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00184	0.0172	CbGeAlD
Thioridazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00159	0.0149	CbGeAlD
Thioridazine—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.00135	0.0127	CbGeAlD
Thioridazine—HTR1A—brainstem—peripheral nervous system neoplasm	0.00134	0.0126	CbGeAlD
Thioridazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00129	0.251	CrCbGaD
Thioridazine—HTR7—brainstem—peripheral nervous system neoplasm	0.00128	0.012	CbGeAlD
Thioridazine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00124	0.0116	CbGeAlD
Thioridazine—DRD2—brainstem—peripheral nervous system neoplasm	0.00121	0.0114	CbGeAlD
Thioridazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00108	0.0101	CbGeAlD
Thioridazine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00106	0.00996	CbGeAlD
Thioridazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.00106	0.206	CrCbGaD
Thioridazine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000839	0.00296	CcSEcCtD
Thioridazine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.000829	0.00292	CcSEcCtD
Thioridazine—Oedema—Melphalan—peripheral nervous system neoplasm	0.000828	0.00292	CcSEcCtD
Thioridazine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000828	0.00292	CcSEcCtD
Thioridazine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000821	0.00289	CcSEcCtD
Thioridazine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000821	0.00289	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000821	0.00289	CcSEcCtD
Thioridazine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000819	0.00288	CcSEcCtD
Thioridazine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000819	0.00288	CcSEcCtD
Thioridazine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000817	0.00288	CcSEcCtD
Thioridazine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000811	0.00286	CcSEcCtD
Thioridazine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000811	0.00286	CcSEcCtD
Thioridazine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000811	0.00286	CcSEcCtD
Thioridazine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000808	0.00285	CcSEcCtD
Thioridazine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000806	0.00284	CcSEcCtD
Thioridazine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.0008	0.00282	CcSEcCtD
Thioridazine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.0008	0.00282	CcSEcCtD
Thioridazine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000799	0.00282	CcSEcCtD
Thioridazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000799	0.0075	CbGeAlD
Thioridazine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000789	0.00278	CcSEcCtD
Thioridazine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00276	CcSEcCtD
Thioridazine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000784	0.00276	CcSEcCtD
Thioridazine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000784	0.00276	CcSEcCtD
Thioridazine—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00275	CcSEcCtD
Thioridazine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.00274	CcSEcCtD
Thioridazine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000776	0.00274	CcSEcCtD
Thioridazine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000774	0.00273	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00271	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00271	CcSEcCtD
Thioridazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000758	0.00267	CcSEcCtD
Thioridazine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000755	0.00266	CcSEcCtD
Thioridazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000752	0.00265	CcSEcCtD
Thioridazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000746	0.00263	CcSEcCtD
Thioridazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000746	0.00263	CcSEcCtD
Thioridazine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000735	0.00259	CcSEcCtD
Thioridazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000734	0.00259	CcSEcCtD
Thioridazine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000732	0.00258	CcSEcCtD
Thioridazine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00073	0.00257	CcSEcCtD
Thioridazine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000729	0.00257	CcSEcCtD
Thioridazine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000729	0.00257	CcSEcCtD
Thioridazine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000728	0.00683	CbGeAlD
Thioridazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000726	0.00256	CcSEcCtD
Thioridazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000723	0.00255	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000721	0.00254	CcSEcCtD
Thioridazine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00072	0.00254	CcSEcCtD
Thioridazine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00072	0.00254	CcSEcCtD
Thioridazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000717	0.00253	CcSEcCtD
Thioridazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000717	0.00253	CcSEcCtD
Thioridazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000716	0.00252	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.00251	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.00251	CcSEcCtD
Thioridazine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000697	0.00246	CcSEcCtD
Thioridazine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000694	0.00244	CcSEcCtD
Thioridazine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000691	0.00244	CcSEcCtD
Thioridazine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000691	0.00244	CcSEcCtD
Thioridazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00069	0.00243	CcSEcCtD
Thioridazine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000686	0.00242	CcSEcCtD
Thioridazine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000681	0.0024	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000677	0.00239	CcSEcCtD
Thioridazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000672	0.00237	CcSEcCtD
Thioridazine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000671	0.00237	CcSEcCtD
Thioridazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000668	0.00236	CcSEcCtD
Thioridazine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000664	0.00234	CcSEcCtD
Thioridazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000663	0.00234	CcSEcCtD
Thioridazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000663	0.00234	CcSEcCtD
Thioridazine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000661	0.0062	CbGeAlD
Thioridazine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000654	0.0023	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000645	0.00227	CcSEcCtD
Thioridazine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00226	CcSEcCtD
Thioridazine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000636	0.00224	CcSEcCtD
Thioridazine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000632	0.00593	CbGeAlD
Thioridazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000625	0.0022	CcSEcCtD
Thioridazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000623	0.0022	CcSEcCtD
Thioridazine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000622	0.00219	CcSEcCtD
Thioridazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000622	0.00219	CcSEcCtD
Thioridazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.00219	CcSEcCtD
Thioridazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000618	0.00218	CcSEcCtD
Thioridazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000618	0.00218	CcSEcCtD
Thioridazine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000615	0.00217	CcSEcCtD
Thioridazine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000613	0.00216	CcSEcCtD
Thioridazine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000613	0.00216	CcSEcCtD
Thioridazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00061	0.00215	CcSEcCtD
Thioridazine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000609	0.00572	CbGeAlD
Thioridazine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000606	0.00214	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.0006	0.00211	CcSEcCtD
Thioridazine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.0006	0.00211	CcSEcCtD
Thioridazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000597	0.0056	CbGeAlD
Thioridazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.0021	CcSEcCtD
Thioridazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000596	0.0021	CcSEcCtD
Thioridazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000594	0.00209	CcSEcCtD
Thioridazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.00209	CcSEcCtD
Thioridazine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000592	0.00209	CcSEcCtD
Thioridazine—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000589	0.00552	CbGeAlD
Thioridazine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000584	0.00206	CcSEcCtD
Thioridazine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000579	0.00204	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000578	0.00203	CcSEcCtD
Thioridazine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000574	0.00202	CcSEcCtD
Thioridazine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000574	0.00202	CcSEcCtD
Thioridazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000572	0.00202	CcSEcCtD
Thioridazine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000567	0.002	CcSEcCtD
Thioridazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00199	CcSEcCtD
Thioridazine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000565	0.00199	CcSEcCtD
Thioridazine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000562	0.00198	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00196	CcSEcCtD
Thioridazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.00195	CcSEcCtD
Thioridazine—Eletriptan—ABCB1—peripheral nervous system neoplasm	0.000546	0.106	CrCbGaD
Thioridazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000544	0.00192	CcSEcCtD
Thioridazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.00192	CcSEcCtD
Thioridazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000542	0.00191	CcSEcCtD
Thioridazine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000542	0.00191	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000538	0.0019	CcSEcCtD
Thioridazine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000538	0.00189	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.00188	CcSEcCtD
Thioridazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000533	0.00188	CcSEcCtD
Thioridazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000533	0.00188	CcSEcCtD
Thioridazine—Rash—Topotecan—peripheral nervous system neoplasm	0.000533	0.00188	CcSEcCtD
Thioridazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000533	0.00188	CcSEcCtD
Thioridazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000533	0.00188	CcSEcCtD
Thioridazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00053	0.00187	CcSEcCtD
Thioridazine—Headache—Topotecan—peripheral nervous system neoplasm	0.00053	0.00187	CcSEcCtD
Thioridazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000529	0.00186	CcSEcCtD
Thioridazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000529	0.00186	CcSEcCtD
Thioridazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000529	0.00186	CcSEcCtD
Thioridazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000528	0.00186	CcSEcCtD
Thioridazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000528	0.00186	CcSEcCtD
Thioridazine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000526	0.00185	CcSEcCtD
Thioridazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000526	0.00185	CcSEcCtD
Thioridazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000526	0.00185	CcSEcCtD
Thioridazine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00185	CcSEcCtD
Thioridazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000524	0.00185	CcSEcCtD
Thioridazine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000524	0.00184	CcSEcCtD
Thioridazine—Rash—Melphalan—peripheral nervous system neoplasm	0.000522	0.00184	CcSEcCtD
Thioridazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000522	0.00184	CcSEcCtD
Thioridazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000516	0.00182	CcSEcCtD
Thioridazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.00051	0.0992	CrCbGaD
Thioridazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00178	CcSEcCtD
Thioridazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000505	0.00178	CcSEcCtD
Thioridazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.00177	CcSEcCtD
Thioridazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000502	0.00177	CcSEcCtD
Thioridazine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.0005	0.00176	CcSEcCtD
Thioridazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000498	0.00176	CcSEcCtD
Thioridazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000498	0.00176	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.00175	CcSEcCtD
Thioridazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000492	0.00173	CcSEcCtD
Thioridazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000489	0.00172	CcSEcCtD
Thioridazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000486	0.00171	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000484	0.00171	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000484	0.00171	CcSEcCtD
Thioridazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000484	0.00171	CcSEcCtD
Thioridazine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00048	0.00169	CcSEcCtD
Thioridazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000473	0.00167	CcSEcCtD
Thioridazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000471	0.00166	CcSEcCtD
Thioridazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000469	0.00165	CcSEcCtD
Thioridazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00165	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000465	0.00164	CcSEcCtD
Thioridazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000464	0.00163	CcSEcCtD
Thioridazine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000463	0.00435	CbGeAlD
Thioridazine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000453	0.00425	CbGeAlD
Thioridazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00159	CcSEcCtD
Thioridazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000451	0.00159	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.00158	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00157	CcSEcCtD
Thioridazine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000446	0.00157	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000445	0.00157	CcSEcCtD
Thioridazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000441	0.00155	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00154	CcSEcCtD
Thioridazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000436	0.00154	CcSEcCtD
Thioridazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.00153	CcSEcCtD
Thioridazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000432	0.00152	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000431	0.00152	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00151	CcSEcCtD
Thioridazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000428	0.00151	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000425	0.0015	CcSEcCtD
Thioridazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000424	0.0015	CcSEcCtD
Thioridazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000419	0.00148	CcSEcCtD
Thioridazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000414	0.0806	CrCbGaD
Thioridazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00146	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.00145	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000409	0.00144	CcSEcCtD
Thioridazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000407	0.00143	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000407	0.00143	CcSEcCtD
Thioridazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.00142	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00142	CcSEcCtD
Thioridazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000401	0.00141	CcSEcCtD
Thioridazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.00141	CcSEcCtD
Thioridazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00141	CcSEcCtD
Thioridazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000398	0.0014	CcSEcCtD
Thioridazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000394	0.0037	CbGeAlD
Thioridazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.00139	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000392	0.00138	CcSEcCtD
Thioridazine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000389	0.00137	CcSEcCtD
Thioridazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000386	0.00136	CcSEcCtD
Thioridazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000386	0.00136	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00136	CcSEcCtD
Thioridazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000384	0.00135	CcSEcCtD
Thioridazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00133	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.00133	CcSEcCtD
Thioridazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000371	0.00131	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000366	0.00129	CcSEcCtD
Thioridazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000364	0.00128	CcSEcCtD
Thioridazine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000359	0.00337	CbGeAlD
Thioridazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.00126	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00123	CcSEcCtD
Thioridazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000344	0.00121	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00121	CcSEcCtD
Thioridazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000342	0.0012	CcSEcCtD
Thioridazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000341	0.0012	CcSEcCtD
Thioridazine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000341	0.0012	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00034	0.0012	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.00114	CcSEcCtD
Thioridazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00113	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00113	CcSEcCtD
Thioridazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000318	0.062	CrCbGaD
Thioridazine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00112	CcSEcCtD
Thioridazine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000316	0.00111	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00111	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000315	0.00111	CcSEcCtD
Thioridazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000313	0.0011	CcSEcCtD
Thioridazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000313	0.0011	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000313	0.0011	CcSEcCtD
Thioridazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000311	0.0011	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00107	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00105	CcSEcCtD
Thioridazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000295	0.00104	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.00103	CcSEcCtD
Thioridazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000291	0.0567	CrCbGaD
Thioridazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00102	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000995	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000988	CcSEcCtD
Thioridazine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000278	0.00098	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00096	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000957	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000947	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000934	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000916	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000914	CcSEcCtD
Thioridazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000258	0.0502	CrCbGaD
Thioridazine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000907	CcSEcCtD
Thioridazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000254	0.0495	CrCbGaD
Thioridazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000888	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000885	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000877	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000871	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000864	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000852	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000847	CcSEcCtD
Thioridazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000838	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000808	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000806	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000788	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000775	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000775	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000747	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000722	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000717	CcSEcCtD
Thioridazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.0002	0.0389	CrCbGaD
Thioridazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000671	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000668	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000623	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00062	CcSEcCtD
Thioridazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000618	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000617	CcSEcCtD
Thioridazine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000614	CcSEcCtD
Thioridazine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000582	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000577	CcSEcCtD
Thioridazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000572	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000571	CcSEcCtD
Thioridazine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000568	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000539	CcSEcCtD
Thioridazine—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.71e-05	0.00045	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.69e-05	0.000446	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	2.67e-05	0.000444	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.67e-05	0.000444	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.67e-05	0.000444	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.67e-05	0.000444	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.65e-05	0.000441	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.56e-05	0.000425	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.55e-05	0.000423	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.54e-05	0.000423	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	2.46e-05	0.000409	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.45e-05	0.000407	CbGpPWpGaD
Thioridazine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.44e-05	0.000405	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.36e-05	0.000393	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.36e-05	0.000392	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.35e-05	0.000391	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.35e-05	0.00039	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.34e-05	0.000388	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.32e-05	0.000386	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.32e-05	0.000385	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	2.31e-05	0.000384	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	2.31e-05	0.000384	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.3e-05	0.000382	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.29e-05	0.00038	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.28e-05	0.000379	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.27e-05	0.000377	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	2.26e-05	0.000375	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.25e-05	0.000374	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.19e-05	0.000364	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.19e-05	0.000364	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.18e-05	0.000362	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.16e-05	0.000358	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	2.12e-05	0.000353	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.11e-05	0.000351	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.09e-05	0.000346	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.08e-05	0.000345	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.06e-05	0.000343	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.04e-05	0.000339	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.04e-05	0.000339	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.02e-05	0.000335	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.01e-05	0.000334	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.01e-05	0.000333	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2e-05	0.000332	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2e-05	0.000332	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.99e-05	0.00033	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000329	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.95e-05	0.000324	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.95e-05	0.000324	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.95e-05	0.000323	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.94e-05	0.000323	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.92e-05	0.000319	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000319	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000319	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.91e-05	0.000318	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.9e-05	0.000315	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.89e-05	0.000314	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.89e-05	0.000314	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.89e-05	0.000314	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.89e-05	0.000313	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.88e-05	0.000313	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.88e-05	0.000313	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.86e-05	0.00031	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000309	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.86e-05	0.000309	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.85e-05	0.000308	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.85e-05	0.000308	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.84e-05	0.000305	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.81e-05	0.0003	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000293	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.74e-05	0.00029	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.74e-05	0.000288	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000288	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000288	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.72e-05	0.000286	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000283	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.7e-05	0.000283	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000282	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.66e-05	0.000276	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.65e-05	0.000275	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.64e-05	0.000272	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.62e-05	0.00027	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.61e-05	0.000267	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.6e-05	0.000266	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000264	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000262	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.53e-05	0.000254	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.52e-05	0.000252	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.51e-05	0.00025	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000249	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.49e-05	0.000248	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.49e-05	0.000248	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.49e-05	0.000247	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.49e-05	0.000247	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.47e-05	0.000244	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.42e-05	0.000237	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.42e-05	0.000236	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.41e-05	0.000235	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000233	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000233	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000232	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.39e-05	0.000231	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000227	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000227	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.36e-05	0.000226	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000225	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.35e-05	0.000225	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.35e-05	0.000225	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.34e-05	0.000222	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000221	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000218	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.3e-05	0.000215	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.28e-05	0.000213	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.28e-05	0.000212	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000209	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.25e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000206	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000206	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.23e-05	0.000204	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000204	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.23e-05	0.000204	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000204	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000201	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.21e-05	0.000201	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.0002	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.21e-05	0.0002	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.0002	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.2e-05	0.0002	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.000199	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000197	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000196	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.18e-05	0.000195	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.16e-05	0.000194	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000188	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000188	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000186	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.1e-05	0.000183	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.1e-05	0.000182	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000182	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000177	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-05	0.000175	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000175	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000173	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.04e-05	0.000173	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.03e-05	0.000172	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.02e-05	0.00017	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000168	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000167	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1e-05	0.000166	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.97e-06	0.000166	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.9e-06	0.000164	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.76e-06	0.000162	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.69e-06	0.000161	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.63e-06	0.00016	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.54e-06	0.000158	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.53e-06	0.000158	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.51e-06	0.000158	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.36e-06	0.000156	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.34e-06	0.000155	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.18e-06	0.000153	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.13e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.13e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.09e-06	0.000151	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.98e-06	0.000149	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.96e-06	0.000149	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.88e-06	0.000147	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.82e-06	0.000147	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.8e-06	0.000146	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.79e-06	0.000146	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.74e-06	0.000145	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.73e-06	0.000145	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.72e-06	0.000145	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.68e-06	0.000144	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.67e-06	0.000144	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.67e-06	0.000144	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.65e-06	0.000144	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.63e-06	0.000143	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.58e-06	0.000142	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.55e-06	0.000142	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.5e-06	0.000141	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.47e-06	0.000141	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.4e-06	0.000139	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.35e-06	0.000139	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.3e-06	0.000138	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.29e-06	0.000138	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.17e-06	0.000136	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.06e-06	0.000134	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8e-06	0.000133	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.95e-06	0.000132	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.93e-06	0.000132	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.91e-06	0.000131	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.87e-06	0.000131	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.82e-06	0.00013	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.79e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.78e-06	0.000129	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.77e-06	0.000129	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.47e-06	0.000124	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.45e-06	0.000124	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.37e-06	0.000122	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.33e-06	0.000122	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.32e-06	0.000122	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.25e-06	0.00012	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.24e-06	0.00012	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.22e-06	0.00012	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.14e-06	0.000119	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.12e-06	0.000118	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.1e-06	0.000118	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.87e-06	0.000114	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.76e-06	0.000112	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.74e-06	0.000112	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.63e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.62e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.6e-06	0.00011	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.42e-06	0.000107	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.39e-06	0.000106	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.31e-06	0.000105	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.15e-06	0.000102	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.14e-06	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.12e-06	0.000102	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.11e-06	0.000102	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.85e-06	9.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.64e-06	9.37e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.55e-06	9.22e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.54e-06	9.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.45e-06	9.05e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.43e-06	9.03e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.42e-06	9.01e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.4e-06	8.96e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.39e-06	8.96e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.31e-06	8.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.29e-06	8.8e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.21e-06	8.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.2e-06	8.63e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.16e-06	8.58e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	5.1e-06	8.47e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.05e-06	8.39e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.83e-06	8.02e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.76e-06	7.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.69e-06	7.78e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	4.68e-06	7.78e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.68e-06	7.77e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.6e-06	7.64e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.59e-06	7.62e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.26e-06	7.08e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	4.05e-06	6.72e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	3.61e-06	6e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.32e-06	5.52e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	3.29e-06	5.47e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.81e-06	4.67e-05	CbGpPWpGaD
